PTHS
Pelthos Therapeutics Inc. Common Stock (PTHS)
$84
About Pelthos Therapeutics Inc. Common Stock (PTHS)
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil. Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.
Details
Daily high
$7.15
Daily low
$6.76
Price at open
$7.00
52 Week High
$32.51
52 Week Low
$6.76
Market cap
28.1M
Dividend yield
-
Volume
74,257
Avg. volume
67,709
P/E ratio
-.31
Pelthos Therapeutics Inc. Common Stock News
Details
Daily high
$7.15
Daily low
$6.76
Price at open
$7.00
52 Week High
$32.51
52 Week Low
$6.76
Market cap
28.1M
Dividend yield
-
Volume
74,257
Avg. volume
67,709
P/E ratio
-.31